All In MedTech

Device Trial Radar · NCT04275089

Early Feasibility Study of the Reia Vaginal Pessary

Early Feasibility Prospective Open-Label Study to Assess the Function of a Novel Pessary for the Non-Surgical Management of Pelvic Organ Prolapse

Last checked: Nov 20, 2026Latest source record: Jul 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

15

Actual

Start

Nov 5, 2020

Primary completion

Jan 20, 2021

Study completion Jan 20, 2021

Sponsor

Lead sponsor
Reia, LLCNot on our public-company list
Sponsor type
Industry
First posted
Feb 19, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an early feasibility open-label non-randomized trial to obtain preliminary information about the function and effectiveness of a novel vaginal pessary for the use in women who suffer from symptoms of pelvic organ prolapse (POP). Recruited patients will have Stage II POP or greater and will be current users of a legally marketed vaginal pessary. In a single visit, data will be collected on the performance and comfort of the subject's current pessary. After placement of a study pessary, comparative data will be collected between subject's current pessary and the study pessary on ability to support prolapse. The study pessary's function will be assessed under controlled circumstances. The patient will have her current pessary replaced at the conclusion of the visit. Results will be used to inform future design modifications of the study pessary.

Conditions

  • Pelvic Organ Prolapse
  • Prolapse

Interventions

  • Reia Vaginal PessaryDevice

    Reia Vaginal Pessary

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Ability of the Study Device to be Retained During Valsalva Compared to the Ability of the Subject's Current Pessary to be Retained During Valsalva (Change in Distance Between Current Pessary and Study Pessary to Leading Edge to the Hymen)Time frame: During treatment - within 1 hour
  2. The Ability of the Study Device to be Retained Throughout Regular Activity (by Vaginal Examination)Time frame: During treatment - within 1 hour

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.